ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-33J8028
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and China Non alcoholic Steatohepatitis NASH Biomarkers Market Insights Forecast to 2027
BUY CHAPTERS

Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Research Report 2025

Code: QYRE-Auto-33J8028
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biopredictive
Quest Diagnostics
Exalenz Bioscience
GENFIT
Siemens Healthineers
ONE WAY LIVER
Prometheus Laboratories
Gilead Sciences

Non-alcoholic Steatohepatitis (NASH) Biomarkers Market

The global market for Non-alcoholic Steatohepatitis (NASH) Biomarkers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers include Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories, Gilead Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-alcoholic Steatohepatitis (NASH) Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-alcoholic Steatohepatitis (NASH) Biomarkers.
The Non-alcoholic Steatohepatitis (NASH) Biomarkers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-alcoholic Steatohepatitis (NASH) Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-alcoholic Steatohepatitis (NASH) Biomarkers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Report

Report Metric Details
Report Name Non-alcoholic Steatohepatitis (NASH) Biomarkers Market
Segment by Type
  • Serum Biomarkers
  • Cytokeratin-18 (CK 18) Marker
  • Inflammatory Markers
  • Others
Segment by Application
  • Hospitals
  • Diagnostic Centers
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-alcoholic Steatohepatitis (NASH) Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report?

Ans: The main players in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market are Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories, Gilead Sciences

What are the Application segmentation covered in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report?

Ans: The Applications covered in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report are Hospitals, Diagnostic Centers, Others

What are the Type segmentation covered in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report?

Ans: The Types covered in the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market report are Serum Biomarkers, Cytokeratin-18 (CK 18) Marker, Inflammatory Markers, Others

1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview
1.1 Product Definition
1.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type
1.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2024 VS 2031)
1.2.2 Serum Biomarkers
1.2.3 Cytokeratin-18 (CK 18) Marker
1.2.4 Inflammatory Markers
1.2.5 Others
1.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application
1.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Estimates and Forecasts
1.4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2020-2031
1.4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2020-2031
1.4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competition by Manufacturers
2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Product Type & Application
2.7 Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Date of Enter into This Industry
2.8 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Situation and Trends
2.8.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players Market Share by Revenue
2.8.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Scenario by Region
3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2020-2031
3.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2020-2025
3.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2026-2031
3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2020-2031
3.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2020-2025
3.3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2026-2031
3.4 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
3.4.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2020-2031)
3.4.3 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
3.5.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2020-2031)
3.5.3 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Region
3.6.1 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
3.7.1 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2020-2031)
3.7.3 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2020-2031)
4.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2020-2025)
4.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2026-2031)
4.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2020-2031)
4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2020-2031)
4.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2020-2025)
4.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2026-2031)
4.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2020-2031)
4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2020-2031)
5.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2020-2025)
5.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2026-2031)
5.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2020-2031)
5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2020-2031)
5.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2020-2025)
5.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2026-2031)
5.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2020-2031)
5.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biopredictive
6.1.1 Biopredictive Company Information
6.1.2 Biopredictive Description and Business Overview
6.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio
6.1.5 Biopredictive Recent Developments/Updates
6.2 Quest Diagnostics
6.2.1 Quest Diagnostics Company Information
6.2.2 Quest Diagnostics Description and Business Overview
6.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio
6.2.5 Quest Diagnostics Recent Developments/Updates
6.3 Exalenz Bioscience
6.3.1 Exalenz Bioscience Company Information
6.3.2 Exalenz Bioscience Description and Business Overview
6.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio
6.3.5 Exalenz Bioscience Recent Developments/Updates
6.4 GENFIT
6.4.1 GENFIT Company Information
6.4.2 GENFIT Description and Business Overview
6.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio
6.4.5 GENFIT Recent Developments/Updates
6.5 Siemens Healthineers
6.5.1 Siemens Healthineers Company Information
6.5.2 Siemens Healthineers Description and Business Overview
6.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio
6.5.5 Siemens Healthineers Recent Developments/Updates
6.6 ONE WAY LIVER
6.6.1 ONE WAY LIVER Company Information
6.6.2 ONE WAY LIVER Description and Business Overview
6.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio
6.6.5 ONE WAY LIVER Recent Developments/Updates
6.7 Prometheus Laboratories
6.7.1 Prometheus Laboratories Company Information
6.7.2 Prometheus Laboratories Description and Business Overview
6.7.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio
6.7.5 Prometheus Laboratories Recent Developments/Updates
6.8 Gilead Sciences
6.8.1 Gilead Sciences Company Information
6.8.2 Gilead Sciences Description and Business Overview
6.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio
6.8.5 Gilead Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Chain Analysis
7.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Mode & Process Analysis
7.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Marketing
7.4.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Channels
7.4.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors
7.5 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customer Analysis
8 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics
8.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Trends
8.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers
8.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
8.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Biopredictive
Quest Diagnostics
Exalenz Bioscience
GENFIT
Siemens Healthineers
ONE WAY LIVER
Prometheus Laboratories
Gilead Sciences
List of Tables
 Table 1. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Product Type & Application
 Table 12. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2020-2025) & (K Units)
 Table 18. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2020-2025)
 Table 19. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2026-2031) & (K Units)
 Table 20. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2026-2031)
 Table 21. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2020-2025) & (K Units)
 Table 27. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2026-2031) & (K Units)
 Table 28. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2020-2025)
 Table 51. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2026-2031)
 Table 52. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2020-2025)
 Table 53. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2026-2031)
 Table 54. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2020-2025)
 Table 61. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2026-2031)
 Table 62. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2020-2025)
 Table 63. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2026-2031)
 Table 64. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2026-2031)
 Table 70. Biopredictive Company Information
 Table 71. Biopredictive Description and Business Overview
 Table 72. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
 Table 74. Biopredictive Recent Developments/Updates
 Table 75. Quest Diagnostics Company Information
 Table 76. Quest Diagnostics Description and Business Overview
 Table 77. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
 Table 79. Quest Diagnostics Recent Developments/Updates
 Table 80. Exalenz Bioscience Company Information
 Table 81. Exalenz Bioscience Description and Business Overview
 Table 82. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
 Table 84. Exalenz Bioscience Recent Developments/Updates
 Table 85. GENFIT Company Information
 Table 86. GENFIT Description and Business Overview
 Table 87. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
 Table 89. GENFIT Recent Developments/Updates
 Table 90. Siemens Healthineers Company Information
 Table 91. Siemens Healthineers Description and Business Overview
 Table 92. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
 Table 94. Siemens Healthineers Recent Developments/Updates
 Table 95. ONE WAY LIVER Company Information
 Table 96. ONE WAY LIVER Description and Business Overview
 Table 97. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
 Table 99. ONE WAY LIVER Recent Developments/Updates
 Table 100. Prometheus Laboratories Company Information
 Table 101. Prometheus Laboratories Description and Business Overview
 Table 102. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
 Table 104. Prometheus Laboratories Recent Developments/Updates
 Table 105. Gilead Sciences Company Information
 Table 106. Gilead Sciences Description and Business Overview
 Table 107. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
 Table 109. Gilead Sciences Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
 Table 113. Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers List
 Table 114. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends
 Table 115. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers
 Table 116. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
 Table 117. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-alcoholic Steatohepatitis (NASH) Biomarkers
 Figure 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Type: 2024 & 2031
 Figure 4. Serum Biomarkers Product Picture
 Figure 5. Cytokeratin-18 (CK 18) Marker Product Picture
 Figure 6. Inflammatory Markers Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Diagnostic Centers
 Figure 12. Others
 Figure 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (2020-2031) & (K Units)
 Figure 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) & (2020-2031)
 Figure 17. Non-alcoholic Steatohepatitis (NASH) Biomarkers Report Years Considered
 Figure 18. Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Manufacturers in 2024
 Figure 19. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players: Market Share by Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers in 2024
 Figure 21. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2020-2031)
 Figure 24. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2020-2031)
 Figure 25. United States Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2020-2031)
 Figure 28. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2020-2031)
 Figure 36. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2020-2031)
 Figure 57. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2020-2031)
 Figure 60. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2020-2031)
 Figure 61. Non-alcoholic Steatohepatitis (NASH) Biomarkers Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Non Alcoholic Steatohepatitis Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Alcoholic Steatohepatitis NASH Treatment Market Insights Forecast to 2030
Global NASH Non alcoholic Steatohepatitis Biomarkers Market Research Report 2024
Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2025
Non Alcoholic Steatohepatitis NASH Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nonalcoholic Steatohepatitis NASH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nonalcoholic Steatohepatitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Alcoholic Steatohepatitis Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nonalcoholic Steatohepatitis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non alcoholic Steatohepatitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NASH Therapeutic Drugs Market Insights Forecast to 2030
Global Genomic Biomarkers Market Research Report 2024
NASH Drug Pipeline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Imaging Biomarker Market Research Report 2025
Global Rare Biomarkers Market Research Report 2024
Global Alcoholic Hepatiti Drug Market Research Report 2024
Global Liver Biopsy Products Market Research Report 2024
Global Cardiac Biomarkers Testing Device Market Research Report 2025
Global Alzheimer s Disease Biomarker Market Research Report 2024
Liver Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions